AI assistant
EKF DIAGNOSTICS HOLDINGS PLC — Director's Dealing 2013
Jun 18, 2013
7617_dirs_2013-06-18_77362671-ec8f-451a-8ab8-dd90aa1090aa.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 2824H
EKF Diagnostics Holdings PLC
18 June 2013
EKF Diagnostics Holdings plc
("EKF" or the "Company" or the "Group")
Director Share Transfer
EKF Diagnostics Holdings plc (AIM: EKF), the growing in-vitro diagnostics company, announces that it received notification on 17 June 2013 from Adam Reynolds, Non-Executive Director of EKF, that he has transferred 100,000 shares of one pence each ("Ordinary Shares") to his daughter as a gift. The transfer took place on 17 June 2013. Adam Reynolds' beneficial interest in the Company following this notification is now 3,176,153 Ordinary Shares, representing 1.16 per cent of the Company's issued share capital.
Enquiries:
| EKF Diagnostics Holdings plc | Tel: 029 2071 0570 | ||
| David Evans, Executive Chairman | Mob: 07740 084 452 | ||
| Julian Baines, CEO | Mob: 07788 420 859 | ||
| Canaccord Genuity Limited | |||
| Lucy Tilley / Henry Fitzgerald-O'Connor / Julian Feneley | Tel: 020 7523 8000 | ||
| Walbrook PR Limited | Tel: 020 7933 8780 | ||
| Paul McManus | Mob: 07980 541 893 or [email protected] | ||
| Paul Cornelius | Mob: 07866 384 707 or [email protected] | ||
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSSFMSUAFDSEFM